\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Missions Horizon EuropeThe Commission launched a call for experts to help developing & deploying a methodology to monitor EU Missions. The aim is to enable the monitoring of EU Missions beyond Horizon Europe, looking at the contribution of other funding programmes at EU and national, as well as at regional and local level towards the achievement of Missions’ objectives. The expert group will have up to 9 independent experts. Deadline for applications is 5 November 2022.
Among the requirements, experts should demonstrate knowledge and experience with EU Missions, in R&I policy analysis, performance measurement of R&I programmes, monitoring and reporting mechanisms of the EU framework programmes. They should also demonstrate a good understanding of the priority-setting, implementation and monitoring of national policies and initiatives. Good knowledge of English is also expected.
Candidates can submit their application via the news item published on the Commission website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
